Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04733287
Other study ID # F2020-023
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date December 31, 2024

Study information

Verified date January 2021
Source Brigham Young University
Contact Jayson Gifford, Ph.D.
Phone 8014223090
Email jaysongifford@byu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Exercise tolerance decreases with age and a sedentary lifestyle. Muscle critical power (CP), is a sensitive measure of exercise tolerance that is more even more relevant to and predictive of endurance performance than VO2max. While recent evidence indicates that CP and muscle function decrease with aging, the cause of this decrease in CP and the best way to mitigate the decrease in CP are unknown. This study will: 1. Measure knee extensor CP in young and old individuals and determine the extent to which changes in muscle oxygen delivery (e.g. resistance artery function, maximum exercise blood flow), muscle mass and composition (e.g. whole-muscle size, muscle fiber cross-sectional area) and mitochondrial oxygen consumption (e.g. maximal coupled respiration of permeabilized fibers biopsied from the knee extensors) contribute to the decrease in CP with age. 2. Examine the effectiveness of two different therapies (1. High Intensity Interval Training, HIIT and 2. Muscle Heat Therapy) at improving muscle function and critical power in young and older adults. 3. Examine the impact of muscle disuse (2 weeks of leg immobilization), a potential contributor to the decrease in muscle function with aging, on muscle function and critical power and determine if heat therapy is an effective means of minimizing the impact of disuse on muscle function and critical power.


Recruitment information / eligibility

Status Recruiting
Enrollment 148
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria: - 18-95 years of age - Currently no cardiovascular or metabolic disease (e.g. heart failure, diabetes) - ability to perform knee extension exercise Exclusion Criteria: - Pregnant - Current cardiovascular or metabolic disease (e.g. heart failure, diabetes) - participating in exercise training within the last 6 months - inability to perform knee extension exercise

Study Design


Intervention

Other:
High Intensity Interval Training of the Knee Extensors
Subjects will perform intense, single leg knee extension exercise 3 times a week for 6 weeks. Specifically, subjects will be seated in a custom knee extension ergometer and perform single leg, dynamic knee extension (similar to single leg cycling) as they perform the exercise. After a 6 minute warm-up at ~20% of that leg's maximum aerobic power (determined during a graded exercise test of single leg knee extension), subjects will perform 4 bouts of 4 minutes at ~80% of maximum aerobic power. Recovery of 4 minutes at ~40% will occur between each bout of exercise. A cool down will be provided at the end of exercise. In total, subjects will perform 40 minutes of single leg knee extension exercise, 3 times a week for 6 weeks. Maximum aerobic power (determined by a graded exercise test) will be determined again at 3 weeks to appropriately adjust the training intensity.
Muscle Heat Therapy
Subjects will receive muscle heat therapy on the knee extensor muscles (short-wave diathermy) for 120 minutes for each visit. Specifically, subjects will lie supine while short-wave diathermy units (Megapulse II) will be placed on the quadriceps femoris and turned on to 800 pulses per second with a pulse duration of 400 microseconds. Our previous research (e.g. Hafen et al 2018- Repeated exposure to heat stress...) has indicated that this treatment raises muscle temperature to ~39C, a similar temperature induced by exercise.
Muscle Disuse
Subjects will undergo 2 weeks of limb immobilization (a model of muscle disuse). Specifically, a knee brace will be placed on one of the subjects' legs and bent to a flexion of 60 degrees to prevent the foot from touching the ground while standing. Subjects will given a pair of crutches and asked to ambulate on crutches for 2 weeks, avoiding bearing any weight with the immobilized leg.
Sham Heat Therapy
Specifically, subjects randomly assigned to the sham group will receive the same treatment as the heat group (same number of visits and set up with the heating units applied to leg for 2 hours each visit) except, unbeknownst to either group, the heating units will never be turned on for the sham group.

Locations

Country Name City State
United States Brigham Young University Provo Utah

Sponsors (1)

Lead Sponsor Collaborator
Brigham Young University

Country where clinical trial is conducted

United States, 

References & Publications (10)

Brunt VE, Howard MJ, Francisco MA, Ely BR, Minson CT. Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans. J Physiol. 2016 Sep 15;594(18):5329-42. doi: 10.1113/JP272453. Epub 2016 Jun 30. — View Citation

Gifford JR, Garten RS, Nelson AD, Trinity JD, Layec G, Witman MA, Weavil JC, Mangum T, Hart C, Etheredge C, Jessop J, Bledsoe A, Morgan DE, Wray DW, Rossman MJ, Richardson RS. Symmorphosis and skeletal muscle V?O2 max : in vivo and in vitro measures reveal differing constraints in the exercise-trained and untrained human. J Physiol. 2016 Mar 15;594(6):1741-51. doi: 10.1113/JP271229. Epub 2016 Jan 19. — View Citation

Gifford JR, Richardson RS. CORP: Ultrasound assessment of vascular function with the passive leg movement technique. J Appl Physiol (1985). 2017 Dec 1;123(6):1708-1720. doi: 10.1152/japplphysiol.00557.2017. Epub 2017 Sep 7. Review. — View Citation

Hafen PS, Abbott K, Bowden J, Lopiano R, Hancock CR, Hyldahl RD. Daily heat treatment maintains mitochondrial function and attenuates atrophy in human skeletal muscle subjected to immobilization. J Appl Physiol (1985). 2019 Jul 1;127(1):47-57. doi: 10.1152/japplphysiol.01098.2018. Epub 2019 May 2. — View Citation

Hafen PS, Preece CN, Sorensen JR, Hancock CR, Hyldahl RD. Repeated exposure to heat stress induces mitochondrial adaptation in human skeletal muscle. J Appl Physiol (1985). 2018 Nov 1;125(5):1447-1455. doi: 10.1152/japplphysiol.00383.2018. Epub 2018 Jul 19. — View Citation

Hanson BE, Proffit M, Gifford JR. Vascular function is related to blood flow during high-intensity, but not low-intensity, knee extension exercise. J Appl Physiol (1985). 2020 Mar 1;128(3):698-708. doi: 10.1152/japplphysiol.00671.2019. Epub 2020 Jan 9. — View Citation

Helgerud J, Høydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, Simonsen T, Helgesen C, Hjorth N, Bach R, Hoff J. Aerobic high-intensity intervals improve VO2max more than moderate training. Med Sci Sports Exerc. 2007 Apr;39(4):665-71. — View Citation

Kim K, Reid BA, Casey CA, Bender BE, Ro B, Song Q, Trewin AJ, Petersen AC, Kuang S, Gavin TP, Roseguini BT. Effects of repeated local heat therapy on skeletal muscle structure and function in humans. J Appl Physiol (1985). 2020 Mar 1;128(3):483-492. doi: 10.1152/japplphysiol.00701.2019. Epub 2020 Jan 23. — View Citation

Park SY, Ives SJ, Gifford JR, Andtbacka RH, Hyngstrom JR, Reese V, Layec G, Bharath LP, Symons JD, Richardson RS. Impact of age on the vasodilatory function of human skeletal muscle feed arteries. Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H217-25. doi: 10.1152/ajpheart.00716.2015. Epub 2015 Nov 20. Erratum in: Am J Physiol Heart Circ Physiol. 2017 Feb 1;312(2):H347. — View Citation

Poole DC, Burnley M, Vanhatalo A, Rossiter HB, Jones AM. Critical Power: An Important Fatigue Threshold in Exercise Physiology. Med Sci Sports Exerc. 2016 Nov;48(11):2320-2334. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle Critical Power Muscle exercise tolerance, quantified as critical power, will be assessed before and after each intervention. The main outcome will be the change in critical power, expressed in Watts, elicited by each intervention.
Specifically, participants will perform 3-5 different power outputs of single leg knee extension exercise as long as they can. Subsequently, the line of best fit between the total work performed and duration of each power output trial will be used to quantify critical power, expressed in Watts.
3-8 weeks
Secondary Resistance Artery Function Resistance Artery Function will be assessed with the Passive Leg Movement (PLM) technique before and after each intervention. The main variable of interest will be the change in peak blood flow elicited by PLM from before to after each intervention.
Specifically, PLM will be performed with a member of the research team moving a subject's knee joint through a 90 degree range of motion, at a rate of 1 Hz for 60 seconds. This passive movement elicits a hyperemic response that will will be quantified with Doppler ultrasound of the femoral artery and expressed in ml/min. The highest 1-second average of blood flow to occur during the movement will be identified as the peak blood flow response.
The main variable of interest will be the change in peak blood flow elicited by PLM from before to after each intervention.
3-8 weeks
Secondary Maximum Exercise Blood Flow The maximum rate of blood flow achieved during exercise will be determined before and after each intervention. The main variable of interest will be the change in maximum exercise blood flow from before to after each intervention, expressed in ml/min.
Specifically, exercise blood flow will be assessed by quantifying the peak hyperemic response, expressed in ml/min, to active single leg knee extension exercise. Following a warm-up, subjects will perform maximal single leg knee extension exercise for 3 minutes while blood flow is quantified with Doppler ultrasound (Logiq E, GE) of the femoral artery. The average rate of blood flow achieved during the final 30 seconds of the exercise will be identified as the maximum exercise blood flow, expressed in ml/min.
3-8 weeks
Secondary Muscle Fiber Size The cross-sectional area of muscle fibers biopsied from the treated vastus lateralis will be used to quantify the size of muscle size before and after each intervention. The main variable of interest will be the change in average myofiber cross-sectional area, expressed in square micrometers, from before to after each intervention.
Specifically, muscle biopsy samples will be mounted on a cork in tragacanth gum . Frozen samples will be adhered to a microscope slide for staining. Slides will be incubated with fluorescently labeled antibodies. CSA will be quantified for each fiber using Olympus CellSens software and subsequently averaged for all fibers on the slide.
3-8 weeks
Secondary Muscle Mitochondrial Function Muscle mitochondrial function will be measured in permeabilized fibers biopsied from the vastus lateralis before and after each intervention.
Specifically, maximal coupled respiration (i.e. OXPHOS or State 3) will be measured with a clark-type electrode (O2K, Oroboros) and expressed in picomoles of oxygen consumed per second.
The main variable of interest will be the change in Maximal Couple Respiration from before to after each intervention.
3-8 weeks
Secondary Vastus Lateralis Cross-Sectional Area The cross-sectional area of the treated vastus lateralis will be measured with magnetic resonance imaging before and after each intervention. The main variable of interest will be the change in cross-sectional area, expressed in square centimeters, from before to after each intervention.
Specifically, MRI will be used to assess whole muscle cross sectional area of the vastus lateralis. Participants will be scanned while laying supine in a 3.0 Tesla MRI scanner (Siemens). A stock Siemens 2-D multi-slice gradient-recalled echo (GRE) MRI pulse sequence will be used. Images will be takin in slices every 5mm, resulting in a total sequence time of approximately 2-min. This will provide cross-sectional images of the vastus lateralis from the base of the femur (distal condyles) up to the groin. .
3-8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A